No new or changed trials today — the tracked registry is unchanged since the last update.

현재 추적 중인 미토콘드리아 임상시험 파이프라인은 총 18건입니다.

주요 임상시험 파이프라인 및 연구 동향

1. 🟢 모집 중 임상시험 (9건)

2. 🟡 진행 및 파이프라인 관찰 대상 (5건)

3. 🔵 완료 및 임상 데이터 확보 (4건)

All Tracked Trials (18)

Increasing Mitochondrial Respiration as a Novel Mechanism for Cognitive Augmentation

NOT_YET_RECRUITING   Phase: NA   Sponsor: Francisco Gonzalez-Lima, PhD

Conditions: Cognition Improvement, Emotion Regulation

NCT07793604 · Start: 2026-10-01

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

NOT_YET_RECRUITING   Phase: PHASE2   Sponsor: Paean Biotechnology Inc.

Conditions: Polymyositis, Dermatomyositis

NCT07122648 · Start: 2025-12

ASCENT: Adipose Stem Cell Mitochondria Supplementation to Oocytes

RECRUITING   Phase: NA   Sponsor: Sunkaky Medical Cooperation

Conditions: Female Infertility, Recurrent Implantation Failures

NCT07066267 · Start: 2025-04-25

A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

RECRUITING   Phase: PHASE1   Sponsor: Minovia Therapeutics Ltd.

Conditions: Myelodysplastic Syndromes

NCT06465160 · Start: 2024-05-27

Vitamin B12 and Folinic Acid Supplementation in Mitochondrial DNA Deletion Syndromes

UNKNOWN   Phase: PHASE1   Sponsor: University of British Columbia

Conditions: Mitochondrial DNA Deletion, Macrocytosis

NCT06186154 · Start: 2024-01

Safety and Therapeutic Effects of Autologous CD34+ Cells Enriched With Allogeneic Placenta-Derived Mitochondria in Pearson Syndrome

RECRUITING   Phase: PHASE2   Sponsor: Minovia Therapeutics Ltd.

Conditions: Mitochondrial Diseases, Pearson Syndrome

NCT06017869 · Start: 2023-07-31

Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure

UNKNOWN (stalled, no update since 2023)   Phase: NA   Sponsor: Peking University People's Hospital

Conditions: Infertility, Female, Elderly

NCT06020742 · Start: 2023-02-09

Co-transplantation of MSC-Derived Exosomes and Autologous Mitochondria for CABG Surgery Patients

UNKNOWN (stalled, no update since 2022)   Phase: PHASE1/PHASE2   Sponsor: Tehran University of Medical Sciences

Conditions: Myocardial Infarction, Myocardial Ischemia, Myocardial Stunning

NCT05669144 · Start: 2022-04-20

A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion

WITHDRAWN   Phase: PHASE1   Sponsor: Minovia Therapeutics Ltd.

Conditions: Primary Mitochondrial Diseases

NCT04548843 · Start: 2022-03-01

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

COMPLETED   Phase: PHASE1/PHASE2   Sponsor: Paean Biotechnology Inc.

Conditions: Polymyositis, Dermatomyositis

NCT04976140 · Start: 2021-12-15

Autologous Mitochondrial Transplant for Cerebral Ischemia

RECRUITING   Phase: NA   Sponsor: University of Washington

Conditions: Cerebral Ischemia

NCT04998357 · Start: 2021-04-29

Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study

RECRUITING   Phase: NA   Sponsor: University Hospital, Angers

Conditions: Septic Shock, Multiple Organ Failure

NCT04288635 · Start: 2020-07-09

Safety and Therapeutic Effects of MNV-BM-BLD Transplantation in Pediatric Pearson Syndrome

COMPLETED   Phase: PHASE1/PHASE2   Sponsor: Minovia Therapeutics Ltd.

Conditions: Mitochondrial Diseases, Pearson Syndrome

NCT03384420 · Start: 2019-02-13

Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies

RECRUITING   Phase: NA   Sponsor: Minovia Therapeutics Ltd.

Conditions: Pregnancy Related

NCT03762512 · Start: 2018-12-01

Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.

UNKNOWN   Phase: NA   Sponsor: Sun Yat-sen University

Conditions: Repetition Failure

NCT03639506 · Start: 2018-09

Transplantation of Autologously Derived Mitochondria Following Ischemia (Boston Children's ECMO trial)

RECRUITING (since 2017)   Phase: NA   Sponsor: Boston Children's Hospital

Conditions: Extracorporeal Membrane Oxygenation Complication

NCT02851758 · Start: 2017-08-02

Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study

COMPLETED   Phase: NA   Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA

Conditions: Infertility

NCT02586298 · Start: 2015-10

Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients

COMPLETED   Phase: NA   Sponsor: University of Helsinki

Conditions: Mitochondrial Myopathies

NCT03973203 · Start: 2014-06-01

Updated today: 2026-09-11